Results 191 to 200 of about 104,306 (283)

A mismatch in enzyme-redox partnerships underlies divergent cytochrome P450 activities between human hepatocytes and microsomes. [PDF]

Commun Biol
Bapiro TE, Martin S, Blacker TS, Wilkinson SD, Orton AL, Hariparsad N, Jones RDO, Duchen MR, Harlfinger S.   +8 more
europepmc   +1 more source

Interaction of cytochrome P450 3A4 with the hydrophilic ligand tetraethylene glycol. [PDF]

Biochem Biophys Res Commun
Sevrioukova IF.
europepmc   +1 more source

Red light-driven enhancement of calycosin biosynthesis in Astragalus membranaceus via functional characterization of AmI3'H. [PDF]

Sci Rep
Seo JW, Choi WH, Lim S, Seong ES.
europepmc   +1 more source

Enzyme engineering of cytochrome P450 RosC provides mechanistic insights into factors controlling iterative oxidation. [PDF]

Appl Microbiol Biotechnol
Iizaka Y, Suzuki H, Sasa N, Ishiuchi K, Kumakiri Y, Kawasaki H, Sato H, Fujimoto K, Noguchi S, Anzai Y.   +9 more
europepmc   +1 more source

Voriconazole-induced Hypoglycemia in a Non-diabetic Patient: A Rare Cause. [PDF]

Clin Med Res
Patel GR, Singh V.
europepmc   +1 more source

Investigating the potential role of metabolic resistance genes in conferring cross-resistance to pyrethroids and polycyclic aromatic hydrocarbon pollutants in the major malaria vector Anopheles coluzzii. [PDF]

BMC Genomics
Muhammad A, Ibrahim SS, Ismail HM, Irving H, Paine MJI, Wondji CS.   +5 more
europepmc   +1 more source

Canine duodenal organoids as a functional platform for intestinal CYP regulation and drug metabolism studies. [PDF]

Drug Metab Dispos
Nakazawa M, Court MH, Ambrosini YM.
europepmc   +1 more source

Application of Physiologically-Based Pharmacokinetic Modeling to Support Drug Labeling: Prediction of CYP3A4-Mediated Pirtobrutinib-Drug Interactions. [PDF]

CPT Pharmacometrics Syst Pharmacol
Tian DD, Hall SD, Chapman SC, Posada MM.
europepmc   +1 more source

Environmentally persistent free radicals lead to selective inhibition of CYP1 monooxygenase activities, and increased production of reactive oxygen species by reaction uncoupling. [PDF]

Front Public Health
Connick JP, Stepter AA, Cawley GF, Eyer MK, Backes WL.   +4 more
europepmc   +1 more source

Optimized <i>Ginkgo biloba</i> extract EGb 761^®: boosted therapeutic benefits with minimized CYP enzyme interference. [PDF]

J Pharm Pharm Sci
Kwon S, Jeong S, Lee S.
europepmc   +1 more source